LA JOLLA, CA—Getting sick with a common cold doesn’t make you immune to COVID-19, but a COVID-19 infection might, at least temporarily, boost the number...
Despite the loss of the company's COVID-19 antibody REGEN-COV earlier in 2022, Regeneron posted a positive first quarter driven primarily by sales of...
The mystery of exactly how the SARS-CoV-2 virus infects human lung cells remains largely hidden to experimental scientists. Now, however, the devilish...
Last week I invited 4 deeply experienced biopharma execs to gather for an hour to discuss what they’ve learned over the years about developing drugs....
Two new sublineages of the Omicron coronavirus variant can dodge antibodies from earlier infection well enough to trigger a new wave, but are far less...
How might one gauge the contributions of selected geographical regions to cancer immunotherapy? Initially, one might assess cancer incidence and prevalence...
As new drug modalities and delivery systems continue to evolve, fresh challenges arise, especially for bioprocessing. Here at GEN, we’ve spoken with...
Humanized in vivo and in vitro systems are becoming more clinically relevant and facilitating better decisions earlier in drug development. The post Animal...
AstraZeneca topped off a very busy week with the company's first-quarter 2022 financial report, citing a total of $11.39 billion in revenue, a whopping...
"Some Misinterpretation" - Fauci Flip-Flops: Walks-Back 'End Of Pandemic' Comments Update (0840ET): Having noted the apparent disconnect between...
Fauci Admits "Pandemic Phase" Of COVID Is Over "We are certainly right now in this country out of the pandemic phase," White House Chief...
Scholars from HSE University and the RAS Institute of Bioorganic Chemistry have demonstrated the efficiency of T-cell immune response against the Omicron...
Enzolytics Inc (OTCMKTS: ENZC) is making an explosive move up the charts after the Company announced a progress update and more on its future plans. The...
Some big themes become apparent as you get into the details on the world’s top 15 R&D players, ranked by overall spending in 2021. Bottom line,...
Uncahareistsed and so far rare cases of liver inflammation (hepatitis) have been appearing in low numbers among young children worldwide since January...
Enzolytics Inc (OTCMKTS: ENZC) is easily one of the most exciting stocks currently trading on the OTCQB; trading 3 tenths of a penny over 52-week lows...
Do a person’s antibodies work to block the COVID-19 virus from infecting one’s system? Are these antibodies also capable of blocking emerging variants...
More than 60 signatories sent a letter sent to the FDA’s Robert Califf and Peter Marks on Thursday urging the agency to include a recommendation for...
Despite all the bad news the COVID-19 pandemic brought upon the world, it has helped us gain a better perspective of our readiness to fend off...
COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in...
The finalists for Health Innovation of the Year at the GeekWire Awards showcase the strength of science and discovery in the Pacific Northwest. Some have...
Research suggests that too-frequent immunizations may lead to a phenomenon called “immune exhaustion.”
The U.S. Food and Drug Administration extended by three months the regulator agency's review of Regeneron Pharmaceuticals Inc.'s application for full approval...
Rapid antigen tests can quickly and conveniently tell a person that they are positive for COVID-19. However, because antibody-based tests aren’t very...
New data on the second booster suggests the older you are, the more you need it.
Fourth doses are now being offered to vulnerable groups. But if you’re young and healthy, will you need one?
Shares of Veru Inc. soared nearly 200 percent after the Florida-based company announced its Phase III COVID-19 antiviral treatment was halted early based...
Building on the success of its COVID-19 mRNA vaccine, Moderna, Inc. is partnering with the nonprofit scientific research organization IAVI to develop treatments...
GAINESVILLE, Fla. — With any highly infectious disease, time can be a killer. Credit: Photo courtesy of Houndstoothe Analytics. GAINESVILLE, Fla. —...
Antibody-drug conjugates (ADCs) have been in development for decades, but only about a dozen have received FDA approval. Approximately 50 biopharma companies...